Keyphrases
IgG4-related Disease (IgG4-RD)
100%
Non-small Cell Lung Cancer (NSCLC)
25%
Lung Cancer
21%
IgG4-positive Plasma Cell
17%
Diagnostic Criteria
13%
Clinical Features
13%
Older Men
11%
Progression-free Survival
11%
Small Cell Lung Cancer
10%
Lung Lesions
10%
Immune Checkpoint Inhibitors
10%
Clinical Course
10%
Human Lung Fibroblasts
10%
Immune Checkpoint Inhibitor Therapy
9%
Monotherapy
9%
Mikulicz's Disease
9%
Lung Field
9%
IgG4-related Respiratory Disease
8%
Autoimmune Pancreatitis
8%
Sirtuin 1 (SIRT1)
8%
Serum IgG4
8%
IgG4-related Kidney Disease
8%
Serum Levels
8%
IgG4-positive
8%
Pathological Features
8%
Lung
8%
Patient Characteristics
7%
Fever
7%
Tumor
7%
Fibrosis
7%
Interleukin-6
7%
Airway Epithelial Cells
7%
Interstitial Pneumonia
7%
Clinical Entities
7%
Adverse Effects
7%
Retrospective multicenter Study
7%
Prognostic Factors
7%
Chemotherapy
6%
Plasma Cell Infiltration
6%
Peripheral Blood Mononuclear Cells
6%
Immunity Genes
6%
Japanese Population
6%
Innate Immunity
6%
C-Jun N-terminal Kinase Signaling
6%
SRT1720
6%
Ionizing Radiation
6%
Elderly Patients
6%
Chronic Pulmonary Aspergillosis
6%
Bradykinin
6%
Bronchiolitis
6%
Medicine and Dentistry
Immunoglobulin G4
67%
IgG4-Related Disease
43%
Disease
30%
Lung
21%
Lung Cancer
21%
Silo-Filler's Disease
15%
Immunoglobulin Producing Cell
15%
Non Small Cell Lung Cancer
15%
Diagnosis
14%
Lung Lesion
12%
Small Cell Lung Cancer
11%
Immune Checkpoint Inhibitor
11%
Disease Course
9%
Epithelial Cell
9%
Mikulicz Disease
9%
Immunoglobulin G4 Related Disease
9%
Glucocorticoid
9%
Chemotherapy
8%
Retrospective Study
8%
Idiopathic Interstitial Pneumonia
8%
Bronchiolitis
7%
Computer Assisted Tomography
7%
Nephropathy
7%
Cellular Infiltration
7%
Fibrosis
7%
Recurrent Disease
6%
Peripheral Blood Mononuclear Cell
6%
Sirtuin1
6%
Lung Aspergillosis
6%
Dyspnea
6%
Autoimmune Pancreatitis
6%
Progression Free Survival
5%
Thorax Radiography
5%
Coughing
5%
Bronchiolitis Obliterans Organizing Pneumonia
5%
Ground Glass Opacity
5%
Clinical Feature
5%
Respiratory Disease
5%
Adverse Event
5%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin G4
25%
Small Cell Lung Cancer
18%
Non Small Cell Lung Cancer
17%
Chemotherapy
14%
Disease
13%
Epidermal Growth Factor Receptor
12%
Immunoglobulin G4 Related Disease
12%
Retrospective Study
11%
Immune Checkpoint Inhibitor
11%
Monotherapy
11%
Adverse Event
10%
Neoplasm
10%
Progression Free Survival
9%
Glucocorticoid
9%
Lung Cancer
8%
Messenger RNA
8%
Protein P53
7%
Interleukin 6
7%
Programmed Death 1 Ligand 1
7%
Phosphotransferase
6%
Overall Survival
6%
Cytokine
6%
Ionizing Radiation
6%
Bradykinin
6%
N [2 [3 (1 piperazinylmethyl)imidazo[2,1 B]thiazol 6 Yl]phenyl] 2 Quinoxalinecarboxamide
6%
Interleukin 8
6%
Asthma
5%
Inflammation
5%
